Sign Up Today and Learn More About INDIGO Biosciences Stock
Invest in or calculate the value of your shares in INDIGO Biosciences or other pre-IPO companies through EquityZen's platform.
INDIGO Biosciences Stock (INOB)
INDIGO Biosciences offers products and services on nuclear receptors, which comprise of therapeutic drug targets.
About INDIGO Biosciences Stock
Founded
2005
Headquarters
Kelayres, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
INDIGO Biosciences Press Mentions
Stay in the know about the latest news on INDIGO Biosciences
INDIGO Biosciences Launches GPR39 Reporter Assay for Metabolic, Gastrointestinal, and Inflammatory Disease Research
einpresswire • Apr 14, 2026
INDIGO Biosciences Achieves Record Revenue in 2025
einpresswire • Mar 31, 2026
INDIGO Biosciences Launches CHRM1 (Cholinergic Receptor, Muscarinic 1) Reporter Assays for Cognitive Drug Discovery
einpresswire • Mar 19, 2026
INDIGO Biosciences Launches PrRPR/GPR10 Reporter Assay for Metabolic, Neuroendocrine, and Cardiometabolic Research
einpresswire • Feb 19, 2026
INDIGO Biosciences Launches AMY1 and AMY3 Receptor Reporter Assays for Metabolic and Neuroendocrine Research
einpresswire • Jan 16, 2026
INDIGO Biosciences Management
Leadership team at INDIGO Biosciences
CFO
Bob Culhane
Chief Scientific Officer
Jack Vanden Heuvel
Join now and verify your accreditation status to gain access to:
- INDIGO Biosciences Current Valuation
- INDIGO Biosciences Stock Price
- INDIGO Biosciences Management
- Available deals in INDIGO Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- INDIGO Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- INDIGO Biosciences Revenue and Financials
- INDIGO Biosciences Highlights
- INDIGO Biosciences Business Model
- INDIGO Biosciences Risk Factors
- INDIGO Biosciences Research Report from SACRA Research
Trading INDIGO Biosciences Stock
How to invest in INDIGO Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like INDIGO Biosciences through EquityZen funds. These investments are made available by existing INDIGO Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell INDIGO Biosciences stock?
Shareholders can sell their INDIGO Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
